Silver Book Fact

Following the current path, pulmonary condition cases will increase by 31.3% between 2003 and 2023. If an alternative path is taken, there will be 9.1% fewer pulmonary condition cases.

DeVol R, Bedroussian A, Charuworn A, et al. An Unhealthy America: The economic burden of chronic disease. The Milken Institute; October 2007. http://www.milkeninstitute.org/publications/publications.taf?function=detail&ID=38801018&cat=ResRep

Reference

Title
An Unhealthy America: The economic burden of chronic disease
Publisher
The Milken Institute
Publication Date
October 2007
Authors
DeVol R, Bedroussian A, Charuworn A, et al
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • The development of antioxidants that reduce oxidative damage is underway. One antioxidant that has been found, uric acid, has an even greater protective effect when combined with tPA.  
  • In 2005, approximately 469,000 coronary artery bypass procedures were performed on 261,000 patients in the U.S.  
  • Compared to predicted levels in the absence of drug therapy, there were 9% fewer deaths from major cardiovascular disease in 2001 and 38% and 25% fewer hospital discharges for stroke…  
  • While treatment with antihypertensives has already generated a benefit-to-cost ratio of at least 6:1 (6:1 for women and 10:1 for men), more effective use of antihypertensive medication would have an…  
  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.